practice areas
FDA & Healthcare Pharmaceuticals & Biologics Medical Devices & Radiological Products Regulatory Science Foods & Dietary Supplements Life Sciencesbar admissions
District of ColumbiaM. Elizabeth Bierman
Email: mebierman@morganlewis.com
|
Washington, D.C.
1111 Pennsylvania Ave., NW Washington, DC 20004-2541 Phone: 202.739.5206 Fax: 202.739.3001 |
education
Catholic University of America, Columbus School of Law, 1986, J.D.
University of Virginia, 1977, B.A.
Publications
| Date | Title | Publication |
| 08/09/1108/09/11 |
FDA Issues Draft Guidance on 510(k) Device Modifications: New Emphasis on Potential Impact of Modifications |
Life Sciences and Healthcare LawFlash |
| 07/28/1107/28/11 |
New FDA Draft Guidance on Mobile Medical Apps Provides Some Clarity, But Raises Many More Questions |
Life Sciences and Healthcare LawFlash |
| 05/23/11May/June 2011 |
FDA Issues Final Rule for Medical Device Data Systems, Classifying Certain Health IT Products, FDLI Update |
Article |
| 02/15/1102/15/11 |
New FDA Rule on Data Systems Has Implications for Device Manufacturers,
Health IT Developers, and Healthcare Providers |
FDA and Healthcare LawFlash |
| 01/19/1101/19/11 |
FDA Preserves 510(k) Pathway; Announces Initial Modifications in Reform Program |
FDA and Healthcare LawFlash |
| 12/03/1012/03/10 |
IRS Requests Comments on New Medical Device Excise Tax |
FDA and Healthcare LawFlash |
| 08/13/1008/13/10 |
FDA Issues Recommendations on 510(k) Reform and Use of Science in Regulatory Decision Making |
FDA and Healthcare LawFlash |
| 04/13/1004/13/10 |
Healthcare Reform Law Imposes New Tax and Other Requirements for Device Manufacturers |
Washington Government Relations and Public Policy LawFlash |
| 05/29/09May/June 2009 |
State Regulation of Medical Device Distribution: Strategic Planning Needed to Address Varying Requirements, FDLI Update |
Article |
| 05/01/09May 2009 |
FDA and Health IT—As Role of Health IT Gains New Significance, Regulators Will Be Keeping Watch, Health Law Analysis |
Article |
| 05/30/08May/June 2008 |
Computer and Software Devices: FDA Seeks Framework for Regulation, FDLI's Update |
Article |
| 04/25/0804/25/08 |
Regulatory Process—Navigating the FDA: Moving from Product Concept to Product Clearance/Approval, presented at Morgan Lewis and Pittsburgh Life Sciences' Spring Training Briefing Series, Pittsburgh |
Speech |
| 04/17/0704/17/07 |
Managing Customer Communications in a Post-Neurontin World, presented at the AdvaMed MTLI Conference: The Regulation of Advertising, Promotion, and Sales of Medical Devices, Washington, D.C. |
Speech |
| 01/01/9601/01/96 |
Impact of the Lobbying Disclosure Act of 1995 On Trade Associations |
White Paper |
| 12/01/9512/01/95 |
The Lobbying Disclosure Act of 1995 |
White Paper |
| 08/01/9208/01/92 |
Environmental Marketing Claims: ML&B White Paper |
White Paper |
| 08/01/90August 1990 |
Product Liability Considerations Applicable To Pharmaceuticals Marketed In The United States, Legal Mind (Japan), Vol. 78 |
Article |
News
| Date | Title | Description |
|---|---|---|
| Jul 13, 2011 |
Morgan Lewis Team Advises Kinetic Concepts on Company’s
$6.3 Billion Acquisition by Apax |
Morgan Lewis advised Kinetic Concepts, Inc. (KCI), on a definitive merger agreement under which a consortium comprised of private equity funds will acquire KCI in a $6.3 billion transaction. |